• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过计算机比较基因组分析鉴定对鲍曼不动杆菌具有潜在非宿主必需性的基因和新型药物靶标。

Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.

机构信息

Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Pakistan.

Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Pakistan.

出版信息

Microb Pathog. 2019 Mar;128:28-35. doi: 10.1016/j.micpath.2018.12.015. Epub 2018 Dec 11.

DOI:10.1016/j.micpath.2018.12.015
PMID:30550846
Abstract

Acinetobacter baumannii, the gram-negative bacteria emerged as an extremely critical pathogen causing nosocomial and different kinds of infections. A. baumannii exhibit resistivity towards various classes of antibiotics that shows that there is a dire need to search more drug targets by exploiting the full genome of the bacteria. In doing so, a strategy is made with the combination of computational biology, pathogen informatics and cheminformatics. Comparative genomics analysis, modeling and docking studies have been performed for the prediction of non-host essential genes and novel drug candidates against A. baumannii. Among 37 unique and 82 common metabolic pathways, 92 genes were predicted as non-host genes. Similarly, using homology search between A. baumannii genome and essential genes of different bacteria, 293 genes were predicted as essential genes of A. baumannii. Among these predicted non-host and essential genes, 86 genes were predicted as non-host essential genes which could serve as potential novel drug and vaccine targets. Additional drug-target like physicochemical properties were estimated such as the molecular weight, subcellular localization and druggability potential. On the structural part, the crystal structures of all the non-host essential genes of A. baumannii were found except the three genes. Out of these three, a homology model of Undecaprenyl-diphosphatase was built using a PDB template by MODELLER [version 9.18]. The quality of the model was assessed by the ProSA and RAMPAGE. The built model was subjected as a receptor for the molecular docking with Adenosine diphosphate (ADP) as a ligand. The molecular docking was performed by AutoDock4 and the best conformation with lowest binding energy (-4.39 kcal/mol) was obtained. The LigPlot was used to identify the close interactions between the ligand the receptor's residues. This study will further aid for the selection of putative inhibitors against a novel drug target identified against A. baumannii and hence could lead to the better therapeutics.

摘要

鲍曼不动杆菌是一种革兰氏阴性细菌,已成为引起医院感染和各种感染的极其重要的病原体。鲍曼不动杆菌对各种类别的抗生素具有耐药性,这表明迫切需要通过利用细菌的全基因组来寻找更多的药物靶点。为此,采用计算生物学、病原体信息学和化学信息学相结合的策略。已经对比较基因组学分析、建模和对接研究进行了研究,以预测非宿主必需基因和针对鲍曼不动杆菌的新型药物候选物。在 37 个独特和 82 个共同代谢途径中,预测了 92 个基因是非宿主基因。同样,通过鲍曼不动杆菌基因组与不同细菌必需基因之间的同源性搜索,预测了 293 个基因是鲍曼不动杆菌的必需基因。在这些预测的非宿主和必需基因中,预测了 86 个基因是非宿主必需基因,它们可以作为潜在的新型药物和疫苗靶点。还估计了额外的药物靶点,如物理化学性质,如分子量、亚细胞定位和药物开发潜力。在结构部分,除了三个基因外,还找到了所有鲍曼不动杆菌非宿主必需基因的晶体结构。在这三个基因中,使用 PDB 模板通过 MODELLER [版本 9.18] 构建了 Undecaprenyl-diphosphatase 的同源模型。使用 ProSA 和 RAMPAGE 评估模型的质量。将构建的模型作为受体,与腺苷二磷酸 (ADP) 作为配体进行分子对接。使用 AutoDock4 进行分子对接,并获得具有最低结合能 (-4.39 kcal/mol) 的最佳构象。使用 LigPlot 识别配体与受体残基之间的紧密相互作用。这项研究将进一步有助于针对鲍曼不动杆菌新型药物靶点选择潜在抑制剂,从而为更好的治疗方法奠定基础。

相似文献

1
Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.通过计算机比较基因组分析鉴定对鲍曼不动杆菌具有潜在非宿主必需性的基因和新型药物靶标。
Microb Pathog. 2019 Mar;128:28-35. doi: 10.1016/j.micpath.2018.12.015. Epub 2018 Dec 11.
2
Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.通过消减基因组学鉴定鲍曼不动杆菌的可成药靶标和 MurA、MurB 的潜在抑制剂。
Appl Biochem Biotechnol. 2013 Sep;171(2):417-36. doi: 10.1007/s12010-013-0372-2. Epub 2013 Jul 12.
3
Comparative subtractive proteomics based ranking for antibiotic targets against the dirtiest superbug: Acinetobacter baumannii.基于比较性消减蛋白质组学的针对最具耐药性超级细菌——鲍曼不动杆菌的抗生素靶点排序
J Mol Graph Model. 2018 Jun;82:74-92. doi: 10.1016/j.jmgm.2018.04.005. Epub 2018 Apr 21.
4
Identification of novel non-homologous drug targets against Acinetobacter baumannii using subtractive genomics and comparative metabolic pathway analysis.使用消减基因组学和比较代谢途径分析鉴定针对鲍曼不动杆菌的新型非同源药物靶标。
Microb Pathog. 2021 Mar;152:104608. doi: 10.1016/j.micpath.2020.104608. Epub 2020 Nov 7.
5
Delineating the Plausible Molecular Vaccine Candidates and Drug Targets of Multidrug-Resistant .鉴定多药耐药结核分枝杆菌的合理分子疫苗候选物和药物靶标
Front Cell Infect Microbiol. 2019 Jun 20;9:203. doi: 10.3389/fcimb.2019.00203. eCollection 2019.
6
Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery.对抗替加环素耐药鲍曼不动杆菌:迈向基于多表位疫苗发现的一大步。
Eur J Pharm Sci. 2019 Apr 30;132:1-17. doi: 10.1016/j.ejps.2019.02.023. Epub 2019 Feb 21.
7
Comparative genomics study of Salmonella Typhimurium LT2 for the identification of putative therapeutic candidates.鼠伤寒沙门氏菌LT2的比较基因组学研究以鉴定潜在治疗候选物。
J Theor Biol. 2015 Mar 21;369:67-79. doi: 10.1016/j.jtbi.2015.01.022. Epub 2015 Jan 28.
8
Screening of potential lead molecules against prioritised targets of multi-drug-resistant-Acinetobacter baumannii - insights from molecular docking, molecular dynamic simulations and in vitro assays.针对多重耐药鲍曼不动杆菌优先靶标的潜在先导分子的筛选——基于分子对接、分子动力学模拟和体外检测的研究。
J Biomol Struct Dyn. 2019 Mar;37(5):1146-1169. doi: 10.1080/07391102.2018.1451387. Epub 2018 Mar 20.
9
Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.代谢途径分析方法:针对耐甲氧西林金黄色葡萄球菌新型治疗靶点的鉴定
Gene. 2015 Feb 10;556(2):213-26. doi: 10.1016/j.gene.2014.11.056. Epub 2014 Nov 28.
10
Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis.从比较蛋白质建模、虚拟筛选、分子动力学模拟和 MM/PBSA 分析角度鉴定鲍曼不动杆菌 MurD 连接酶的潜在分子。
J Mol Model. 2020 Oct 17;26(11):304. doi: 10.1007/s00894-020-04557-4.

引用本文的文献

1
Identification and Functional Annotation of Hypothetical Proteins of Pan-Drug-Resistant Strain MRSN845308 Toward Designing Antimicrobial Drug Targets.泛耐药菌株MRSN845308假定蛋白的鉴定与功能注释以用于设计抗菌药物靶点
Bioinform Biol Insights. 2024 Sep 23;18:11779322241280580. doi: 10.1177/11779322241280580. eCollection 2024.
2
DNA damage response coregulator affects many cellular pathways and processes in 17978.DNA损伤反应共调节因子影响17978中的许多细胞途径和过程。
Front Cell Infect Microbiol. 2024 Jan 11;13:1324091. doi: 10.3389/fcimb.2023.1324091. eCollection 2023.
3
Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections.
革兰氏阴性菌感染抗生素研发的未竟目标。
Nat Rev Drug Discov. 2023 Dec;22(12):957-975. doi: 10.1038/s41573-023-00791-6. Epub 2023 Oct 13.
4
Proteomics approaches: A review regarding an importance of proteome analyses in understanding the pathogens and diseases.蛋白质组学方法:关于蛋白质组分析在理解病原体和疾病方面重要性的综述。
Front Vet Sci. 2022 Dec 15;9:1079359. doi: 10.3389/fvets.2022.1079359. eCollection 2022.
5
Computer-Based Identification of Potential Druggable Targets in Multidrug-Resistant : A Combined In Silico, In Vitro and In Vivo Study.基于计算机的多重耐药潜在可成药靶点鉴定:一项计算机模拟、体外和体内联合研究
Microorganisms. 2022 Oct 5;10(10):1973. doi: 10.3390/microorganisms10101973.
6
Promising Vaccine Candidates and Drug Targets in Recent Years.近年来有前景的疫苗候选物和药物靶点。
Front Immunol. 2022 May 26;13:900509. doi: 10.3389/fimmu.2022.900509. eCollection 2022.
7
Research on the Computational Prediction of Essential Genes.必需基因的计算预测研究
Front Cell Dev Biol. 2021 Dec 6;9:803608. doi: 10.3389/fcell.2021.803608. eCollection 2021.
8
Genome-Based Drug Target Identification in Human Pathogen .基于基因组的人类病原体药物靶点鉴定
Front Genet. 2021 Mar 25;12:564056. doi: 10.3389/fgene.2021.564056. eCollection 2021.
9
Genome Subtraction and Comparison for the Identification of Novel Drug Targets against subsp. .用于鉴定针对亚种的新型药物靶点的基因组扣除与比较
Pathogens. 2020 May 12;9(5):368. doi: 10.3390/pathogens9050368.
10
New Therapeutic Candidates for the Treatment of Malassezia pachydermatis -Associated Infections.用于治疗马拉色菌相关感染的新型治疗候选药物。
Sci Rep. 2020 Mar 17;10(1):4860. doi: 10.1038/s41598-020-61729-1.